Evidence map›Paper›PMID 35854857›Full record

ArticleThe Australian journal of cancer nursing2022

Peripheral intravenous catheters in the care of oncology and haematology patients.

Emily N Larsen, Gillian Ray-Barruel, Mari Takashima, Nicole Marsh, Christopher R Friese, Vineet Chopra, Evan Alexandrou, Claire M Rickard

Open access · greenAbstract read
In one paragraph

Article in The Australian journal of cancer nursing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Emily N LarsenSchool of Nursing and Midwifery, Griffith University, Brisbane, QLD, Australia.
Gillian Ray-BarruelAlliance for Vascular Access Teaching and Research, Griffith University, Brisbane, QLD, Australia.
Mari TakashimaSchool of Nursing and Midwifery, Griffith University, Brisbane, QLD, Australia.
Nicole MarshSchool of Nursing and Midwifery, Griffith University, Brisbane, QLD, Australia.
Christopher R FrieseSchool of Nursing and Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, USA.
Vineet ChopraDepartment of Medicine, University of Colorado, Denver, Colorado 80204, USA.
Evan AlexandrouAlliance for Vascular Access Teaching and Research, Griffith University, Brisbane, QLD, Australia.
Claire M RickardSchool of Nursing and Midwifery, Griffith University, Brisbane, QLD, Australia.
Griffith University · AUThe University of Queensland · AULiverpool Hospital · AUMetro South Health · AU

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
Interdisciplinary Research Training Center in Cancer Care DeliveryT32CA236621 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Lauren P Wallner · 2020 to 2026
$2.8M
Multi-Modal Interprofessional Training to Improve Chemotherapy SafetyR25CA214227 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FRIESE, CHRISTOPHER R · 2017 to 2021
$1.2M
NCI NIH HHS P30 CA046592NCI NIH HHS R25 CA214227NCI NIH HHS T32 CA236621
6 · The paper itself

Abstract

Aim: To determine peripheral intravenous catheter (PIVC) characteristics, complications and risk factors among patients in cancer units. Methods: A secondary analysis of a global, cross-sectional study (127 hospitals in 24 countries). Participants (≥18 years) admitted to cancer units were assessed once for PIVC characteristics and the presence of complications. Variables included patient demographics, device characteristics, treatment details, and device and/or site complications. PIVC characteristics were presented using qualitative descriptors; mixed-effects logistic regression models determined risk factors for PIVC complications. Results: In total, 1,807 participants (1,812 PIVCs) were included; 12% (n=215) of PIVCs presented with complications. Risk factors included: insertion by doctors; insertion in ED and ambulance/other locations; poor PIVC dressing integrity; dwell time ≥49 hours; and administration of colloids/blood products and antiemetics. Conclusions: At least one in ten PIVCs in cancer units present with complications; regular PIVC assessment and improved dressing integrity is likely to reduce risk and improve outcomes.

Indexed as

haematologyoncologyperipheral venous catheter

Identifiers

PMID35854857
PMCPMC9288653
OpenAlexW4283271486

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.